Clinical Trials Logo

Dysfunctional Voiding clinical trials

View clinical trials related to Dysfunctional Voiding.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06040333 Completed - Clinical trials for Dysfunctional Voiding

Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

NCT ID: NCT05313984 Completed - Fecal Incontinence Clinical Trials

OptiLUTS Part C: The Development of a Symptom Assessment Tool in Sacral Neuromodulation.

OptiLUTS
Start date: March 1, 2018
Phase:
Study type: Observational

Sacral neuromodulation (SNM) is a two-staged 2nd-line therapy for therapy-resistant LUTS and fecal incontinence. Currently, the assessment of symptoms at baseline and after stage I is directed towards a discipline related evaluation. The OptiLUTS trial strives for a more holistic approach, taking all pelvic floor dysfunctions into account. A holistic assessment tool will be developed and SNM-care pathway will be set-up.

NCT ID: NCT02806713 Completed - Postoperative Pain Clinical Trials

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

EPIPhANy
Start date: February 2016
Phase: Phase 3
Study type: Interventional

Randomized clinical trial using phenazopyridine to decrease voiding dysfunction after a retropubic midurethral sling operation.

NCT ID: NCT01733290 Completed - Clinical trials for Dysfunctional Voiding

Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

Start date: October 2012
Phase: Phase 2
Study type: Interventional

This study is designed and aimed at determine the clinical efficacy of BoNT-A on patients with dysfunctional voiding. The results of this study can provide further information for patient selection and therapeutic duration.